These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 15152734)

  • 21. The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society.
    North American Menopause Society
    Menopause; 2007; 14(3 Pt 1):355-69; quiz 370-1. PubMed ID: 17438512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urogenital atrophy: diagnosis, sequelae, and management.
    Keil K
    Curr Womens Health Rep; 2002 Aug; 2(4):305-11. PubMed ID: 12150759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oestradiol-releasing vaginal ring for treatment of postmenopausal urogenital atrophy.
    Smith P; Heimer G; Lindskog M; Ulmsten U
    Maturitas; 1993 Mar; 16(2):145-54. PubMed ID: 8483427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hormone replacement therapy: the pros].
    Jamin C; Madelenat P
    Gynecol Obstet Fertil; 2008 Jan; 36(1):98-103. PubMed ID: 18248839
    [No Abstract]   [Full Text] [Related]  

  • 25. Genitourinary Syndrome Of Menopause and Vaginal Estrogen Use.
    Steele NM; Ledbetter CA; Bernier F
    Urol Nurs; 2016; 36(2):59-65, 71. PubMed ID: 27281861
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [What all women should know about menopause].
    Wasaha S; Angelopoulos FM
    Servir; 1996; 44(6):298-307. PubMed ID: 9006273
    [No Abstract]   [Full Text] [Related]  

  • 27. Menopause international. The integrated journal of postreproductive health. Note from the editor.
    Studd J
    Menopause Int; 2009 Jun; 15(2):47. PubMed ID: 19465666
    [No Abstract]   [Full Text] [Related]  

  • 28. Vaginal hormone therapy for urogenital and menopausal symptoms.
    Ballagh SA
    Semin Reprod Med; 2005 May; 23(2):126-40. PubMed ID: 15852198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estrogens and progestins: background and history, trends in use, and guidelines and regimens approved by the US Food and Drug Administration.
    Stefanick ML
    Am J Med; 2005 Dec; 118 Suppl 12B():64-73. PubMed ID: 16414329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Should urogenital atrophy in breast cancer survivors be treated with topical estrogens?
    Trinkaus M; Chin S; Wolfman W; Simmons C; Clemons M
    Oncologist; 2008 Mar; 13(3):222-31. PubMed ID: 18378532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estrogen therapy in women over 60 years of age.
    Studd J; Zamblera D
    Gynecol Endocrinol; 1994 Sep; 8(3):191-6. PubMed ID: 7847104
    [No Abstract]   [Full Text] [Related]  

  • 32. FAQs in hormone replacement therapy.
    Mansour D
    Practitioner; 2005 Nov; 249(1676):778-82. PubMed ID: 16296654
    [No Abstract]   [Full Text] [Related]  

  • 33. Postmenopausal osteoporosis and hormone replacement therapy.
    Gambacciani M; Vacca F
    Minerva Med; 2004 Dec; 95(6):507-20. PubMed ID: 15785435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Menopause].
    d'Arailh AS; Lopes P
    Rev Prat; 2006 Oct; 56(16):1841-6. PubMed ID: 17315513
    [No Abstract]   [Full Text] [Related]  

  • 35. Vulvovaginal atrophy: new and upcoming approaches.
    Simon JA
    Menopause; 2009; 16(1):5-7. PubMed ID: 19131842
    [No Abstract]   [Full Text] [Related]  

  • 36. [Menopause. Nutritional and therapeutic care].
    Rev Infirm; 2000 Jan; (56):24-5. PubMed ID: 10876567
    [No Abstract]   [Full Text] [Related]  

  • 37. The menopausal transition: how does route of delivery affect the risk/benefit ratio of hormone therapy?
    Shulman LP
    J Fam Pract; 2004 Jul; Suppl():S13-7. PubMed ID: 15251108
    [No Abstract]   [Full Text] [Related]  

  • 38. If my wife had osteoporosis.
    Francis RM
    Br J Clin Pract; 1989 Mar; 43(3):109-11. PubMed ID: 2611114
    [No Abstract]   [Full Text] [Related]  

  • 39. Updated practical recommendations for hormone replacement therapy in the peri- and postmenopause.
    Birkhäuser MH; Panay N; Archer DF; Barlow D; Burger H; Gambacciani M; Goldstein S; Pinkerton JA; Sturdee DW
    Climacteric; 2008 Apr; 11(2):108-23. PubMed ID: 18365854
    [No Abstract]   [Full Text] [Related]  

  • 40. Hormone replacement therapy in postmenopausal women.
    Prelevic GM; Kocjan T; Markou A
    Minerva Endocrinol; 2005 Mar; 30(1):27-36. PubMed ID: 15877011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.